42 studies found for:    " March 19, 2008":" April 18, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Abacavir
22 Completed
Has Results
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Entecavir with continued standard of care antiretroviral therapy;   Drug: continued standard of care with tenofovir in addition to emtricitabine or lamivudine
23 Completed Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China
Conditions: HIV Infections;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Physician Ai Shi Zi training;   Drug: Standard care;   Behavioral: Patient risk-reduction counseling
24 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 1;   Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 2
25 Completed Adult Sexual Risk Behavior Among Women With a History of Childhood Sexual Abuse
Conditions: HIV Infections;   Child Abuse, Sexual
Interventions: Behavioral: Information-Motivation-Behavioral Skills model;   Behavioral: Traumagenic Dynamics model
26 Completed
Has Results
HIV Screening in the Emergency Department Setting
Condition: HIV Infections
Interventions: Other: Targeted Screening;   Other: Routine Screening
27 Completed Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT
Conditions: HIV Infections;   Tuberculosis
Interventions: Device: QuantiFERON TB Gold In-Tube;   Device: T-SPOT.TB®
28 Completed CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy
Conditions: HIV Infections;   AIDS
Interventions: Procedure: Upper Endoscopy and biopsies;   Drug: raltegravir;   Drug: efavirenz
29 Completed Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate;   Drug: Tenofovir DF placebo
30 Completed Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial
Condition: HIV Infections
Interventions: Drug: EFV+TDF;   Drug: EFV+3TC+TDF
31 Completed A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744
Condition: HIV Infection
Intervention: Drug: GSK1265744
32 Completed China Adherence for Life
Condition: HIV Infections
Intervention: Behavioral: Electronic drug monitoring feedback intervention
33 Unknown  Impact of Antiretroviral Therapy on Cardiac Biomarkers
Condition: HIV Infections
Intervention:
34 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions
35 Terminated Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Nevirapine
36 Completed Metabolic Effects of Enfuvirtide in Healthy Volunteers
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Placebo
37 Suspended Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort
Condition: HIV Infections
Interventions: Drug: Ibandronate;   Behavioral: Lifestyle modifications
38 Completed Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
Condition: HIV Infections
Interventions: Drug: Vacc-4x;   Drug: Sterile water
39 Completed Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Condition: Human Immunodeficiency Virus
Intervention: Drug: lopinavir/ritonavir
40 Completed TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.
Condition: HIV
Intervention: Drug: TMC114; darunavir; Prezista

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results
Indicates status has not been verified in more than two years